GS-CA compounds: First-in-class HIV-1 capsid inhibitors covering multiple grounds. Singh K, Gallazzi F, Hill KJ, Burke DH, Lange MJ, Quinn TP, Neogi U, Sönnerborg A. Frontiers in Microbiology; 10(JUN):1227.
Featured in this article:
Kamlendra Singh,
Fabio Gallazzi,
Donald Burke-Agüero,
Margaret Lange,
Thomas Quinn.
Go to article...